Nome Químico: (1R,2R)-2-(3-((5-Acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium 2,2,2-trifluoroacetate
Sorrisos: COC1=C(OC)C=C(C[C@]2([H])C(C=C(OC)C(OC)=C3)=C3CC[N@+]2(C)CCC(OCCCCCOC(C)=O)=O)C=C1.O=C([O-])C(F)(F)F
Inchi: InChI=1S/C53H72N2O12.2C2HF3O2/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6;2*3-2(4,5)1(6)7/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3;2*(H,6,7)/q+2;;/p-2/t42-,43+,54-,55-;;/m0../s1
HPLC determination of cisatracurium besylate and propofol mixtures with LC-MS identification of degradation products
By Zhang H; Wang P; Bartlett M G; Stewart J T
From Journal of pharmaceutical and biomedical analysis (1998), 16(7), 1241-9